Interleukin-17A is a protein that in humans is encoded by the IL17A gene. In rodents, IL-17A used to be referred to as CTLA8, after the similarity with a viral gene. From Wikipedia
Positive Phase III Sunshine and Sunrise trials showed clinically relevant reductions in inflammatory lesions alongside lower pain levels in adults unresponsive to standard therapy.
